{"id":24843,"date":"2026-07-12T12:32:01","date_gmt":"2026-07-12T12:32:01","guid":{"rendered":"https:\/\/thestrategystory.com\/blog\/?p=24843"},"modified":"2026-07-12T12:32:45","modified_gmt":"2026-07-12T12:32:45","slug":"stryker-business-model-how-stryker-makes-money","status":"publish","type":"post","link":"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/","title":{"rendered":"Stryker Business Model: How Stryker Makes Money"},"content":{"rendered":"\n

Stryker Corporation is a global leader in medical technologies<\/strong> dedicated to improving healthcare through innovative medical devices, surgical technologies, and digital healthcare solutions. Guided by its mission, “Together with our customers, we are driven to make healthcare better,”<\/strong> the company develops products and services across MedSurg, Neurotechnology, and Orthopaedics<\/strong> that help improve patient and healthcare outcomes. Through its broad portfolio of technologies, Stryker impacts more than 150 million patients annually<\/strong>. Founded in 1941<\/strong> by renowned orthopedic surgeon Dr. Homer H. Stryker<\/strong> and incorporated in 1946<\/strong>, the company has grown into one of the world’s leading medical device manufacturers.<\/p>\n\n\n\n

Stryker markets its products in approximately 61 countries<\/strong> through company-owned subsidiaries, branches, and third-party distributors. Its customer base primarily includes hospitals, healthcare systems, physicians, surgeons, and other healthcare facilities<\/strong>. The company’s portfolio spans a wide range of medical specialties and includes surgical equipment, surgical navigation systems, endoscopic imaging systems, patient handling equipment, emergency medical devices, intensive care products, artificial intelligence-assisted virtual care platforms, stroke treatment devices, orthopedic implants, trauma products, and the Mako robotic-arm assisted surgical system<\/strong>. Most of these products are marketed directly to healthcare providers, enabling Stryker to maintain close relationships with hospitals and clinicians worldwide.<\/p>\n\n\n\n

Stryker operates through two reportable business segments: MedSurg and Neurotechnology<\/strong> and Orthopaedics<\/strong>. The MedSurg and Neurotechnology segment includes surgical equipment, endoscopy, medical technologies, vascular products, and neurocranial solutions, while the Orthopaedics segment focuses on joint replacement implants, trauma and extremity products, spinal implants, and robotic-assisted surgical technologies. Supported by continuous innovation, strategic acquisitions, and investments in research and development, Stryker continues to expand its global presence while helping healthcare providers deliver safer, more efficient, and better clinical outcomes.<\/p>\n\n\n\n

Industry Background and the Problem<\/h2>\n\n\n\n

The medical technology industry plays a critical role in helping healthcare providers diagnose, treat, and manage a wide range of medical conditions. Hospitals, physicians, and healthcare systems increasingly seek technologies that improve clinical outcomes, enhance surgical precision, reduce recovery times, and improve patient safety. Demand for advanced medical devices continues to grow as aging populations, the rising prevalence of chronic diseases, and increasing volumes of orthopedic, neurological, cardiovascular, and minimally invasive procedures place greater pressure on healthcare systems worldwide. At the same time, healthcare providers are expected to deliver higher-quality care while improving operational efficiency and controlling costs, creating demand for innovative technologies that support better patient outcomes and streamlined clinical workflows.<\/p>\n\n\n\n

The industry is also highly competitive and innovation-driven. Stryker competes across multiple product categories with leading global medical technology companies, including surgical equipment, endoscopy, patient handling, neurotechnology, vascular interventions, orthopedic implants, and robotic-assisted surgery. Success depends on the continuous development of new products and the improvement of existing technologies. Companies must invest heavily in research and development while anticipating evolving clinical needs and rapidly introducing innovations such as robotics, artificial intelligence, and connected healthcare solutions. Failure to innovate can quickly reduce market share as hospitals increasingly adopt newer technologies that improve surgical accuracy, efficiency, and patient care.<\/p>\n\n\n\n

Medical device manufacturers also operate in one of the world’s most highly regulated industries. In the United States, many new products require clearance or approval from the Food and Drug Administration (FDA)<\/strong> before commercialization, while international markets impose their own regulatory requirements, including the European Union Medical Device Regulation (MDR)<\/strong>. Beyond product approvals, manufacturers must comply with stringent quality system regulations, manufacturing standards, clinical evidence requirements, post-market surveillance obligations, and ongoing inspections. These regulatory processes increase the cost and complexity of bringing new technologies to market while creating significant barriers to entry for competitors.<\/p>\n\n\n\n

In addition to regulatory complexity, healthcare providers and governments continue to implement cost-containment measures<\/strong> aimed at controlling healthcare spending. Hospitals face increasing pricing pressure from public and private payers, reimbursement changes, provider consolidation, and competitive purchasing processes. At the same time, manufacturers must manage global supply chain challenges, inflation, geopolitical risks, and evolving cybersecurity requirements while continuing to invest in product innovation. Stryker believes long-term success depends on combining continuous innovation, high-quality products, strong customer relationships, and strategic investments in emerging technologies such as robotic-assisted surgery, artificial intelligence, and minimally invasive medical solutions that improve both patient outcomes and healthcare efficiency.<\/p>\n\n\n\n

How Stryker Solves the Problem<\/strong><\/h2>\n\n\n\n

Stryker addresses the evolving needs of healthcare providers by developing innovative medical technologies that improve surgical precision, enhance patient safety, streamline clinical workflows, and support better healthcare outcomes. The company combines advanced medical devices, robotic-assisted surgery, digital healthcare solutions, and minimally invasive technologies to help physicians and hospitals deliver more effective patient care. Its operations are organized into two reportable business segments\u2014MedSurg and Neurotechnology<\/strong> and Orthopaedics<\/strong>\u2014allowing Stryker to serve a broad range of medical specialties through a comprehensive portfolio of products and services.<\/p>\n\n\n\n

The MedSurg and Neurotechnology<\/strong> segment provides technologies used throughout hospitals and surgical environments. Its Instruments<\/strong> business offers surgical equipment, operating room technologies, and surgical navigation systems that help surgeons perform procedures with greater accuracy and efficiency. The Endoscopy<\/strong> business supplies advanced endoscopic imaging systems, communication platforms, and operating room integration technologies such as the 1788 Camera platform<\/strong> and Connected OR IP BRAVoE<\/strong>, enabling clinicians to visualize procedures more clearly and improve collaboration during surgery. Meanwhile, the Medical<\/strong> business provides patient handling equipment, emergency medical devices, intensive care disposable products, and clinical communication solutions, including the LIFEPAK 35 monitor\/defibrillator<\/strong> and Vocera Sync Badge<\/strong>, which combines real-time communication with AI-assisted virtual care workflows to enhance patient care and hospital efficiency.<\/p>\n\n\n\n

Within the same segment, Stryker’s Vascular<\/strong> business develops minimally invasive devices for treating acute ischemic stroke, hemorrhagic stroke, and venous thromboembolism. Following the acquisition of Inari Medical<\/strong> in 2025, the company expanded its vascular portfolio to include additional minimally invasive therapies for venous diseases. The Neuro Cranial<\/strong> business complements these offerings with products used in traditional brain and skull-based surgical procedures, orthobiologics, synthetic bone grafts, vertebral augmentation systems, and technologies such as OptaBlate BVN<\/strong> for treating vertebrogenic pain. Together, these businesses enable Stryker to support physicians across neurosurgery, stroke intervention, emergency medicine, and other specialized clinical areas.<\/p>\n\n\n\n

The Orthopaedics<\/strong> segment focuses on restoring patient mobility through advanced implant technologies and robotic-assisted surgery. The company develops implants for hip, knee, shoulder, trauma, extremity, ankle, and spinal procedures<\/strong>, supported by specialized surgical instrumentation and digital planning tools. A cornerstone of this segment is Mako SmartRobotics<\/strong>, Stryker’s robotic-arm assisted surgical platform, which is now available in more than 45 countries<\/strong>. During 2025, the company introduced the Mako 4 platform<\/strong>, expanding its capabilities through the Q-Guidance<\/strong> system and launching advanced applications such as Mako Total Hip with Advanced Primary and Revision<\/strong>. Stryker also continued developing Mako Shoulder<\/strong>, integrating robotic guidance with its Tornier implant portfolio to improve surgical planning and execution. These technologies help surgeons perform procedures with greater precision while improving consistency and patient outcomes.<\/p>\n\n\n\n

Beyond product innovation, Stryker strengthens its market position through a direct commercial model and continuous portfolio expansion. Most of its products are marketed directly to physicians, hospitals, and healthcare facilities<\/strong>, enabling close collaboration with healthcare professionals and rapid adoption of new technologies. The company also complements internal innovation with strategic acquisitions, including Guard Medical<\/strong>, Advanced Medical Balloons<\/strong>, and Inari Medical<\/strong>, which expanded its capabilities in wound care, patient management, and vascular therapies. Supported by ongoing investments in research and development, robotics, artificial intelligence, and digital healthcare technologies, Stryker continues to develop comprehensive solutions that help healthcare providers improve clinical outcomes while making healthcare safer, more efficient, and more connected.<\/p>\n\n\n\n

Stryker Business Model<\/strong><\/h2>\n\n\n\n

Stryker operates a medical technology innovation business model<\/strong> focused on developing, manufacturing, marketing, and supporting advanced medical devices that improve patient outcomes and healthcare efficiency. The company combines continuous research and development, strategic acquisitions, global manufacturing capabilities, and direct customer relationships to deliver innovative solutions across multiple medical specialties. Its portfolio spans surgical equipment, orthopedic implants, robotic-assisted surgery, neurotechnology, emergency medical products, and digital healthcare solutions, enabling Stryker to serve hospitals, physicians, and healthcare systems throughout the patient care continuum.<\/p>\n\n\n\n

The company’s operations are organized into two reportable business segments: MedSurg and Neurotechnology<\/strong> and Orthopaedics<\/strong>. The MedSurg and Neurotechnology<\/strong> segment provides surgical equipment, endoscopic imaging systems, patient handling technologies, emergency medical equipment, vascular intervention devices, neurocranial products, and AI-assisted virtual care platforms. The Orthopaedics<\/strong> segment develops implants for joint replacement, trauma, extremities, shoulder, ankle, and spinal procedures while supporting surgeons with specialized instrumentation and robotic-assisted surgical technologies. This diversified portfolio allows Stryker to participate in multiple high-growth areas of the global medical technology market while reducing dependence on any single product category.<\/p>\n\n\n\n

A defining feature of Stryker’s business model is its direct commercial approach<\/strong>. Most of the company’s products are marketed directly to hospitals, surgeons, physicians, and other healthcare facilities<\/strong>, enabling close collaboration with healthcare professionals throughout product development, clinical adoption, and ongoing support. This direct relationship helps Stryker better understand customer needs, accelerate product adoption, and build long-term partnerships with healthcare providers. In addition to selling capital equipment such as surgical systems and robotic platforms, the company generates recurring demand through implants, disposable medical products, surgical instruments, and accessories that are used repeatedly in clinical procedures.<\/p>\n\n\n\n

Innovation is central to Stryker’s business model. The company continuously invests in research and development to introduce new technologies such as Mako SmartRobotics<\/strong>, Q-Guidance<\/strong>, AI-assisted clinical communication platforms, advanced endoscopic imaging systems, and minimally invasive vascular devices. Strategic acquisitions\u2014including Inari Medical<\/strong>, Guard Medical<\/strong>, and Advanced Medical Balloons<\/strong>\u2014complement internal innovation by expanding Stryker’s capabilities in vascular intervention, wound care, and patient management. These acquisitions allow the company to broaden its product portfolio while entering adjacent medical technology markets with established solutions.<\/p>\n\n\n\n

Stryker’s competitive advantage is further strengthened by its global manufacturing, intellectual property, and regulatory capabilities. The company owns approximately 5,600 U.S. patents<\/strong> and 9,000 international patents<\/strong>, while compliance with stringent regulatory standards, including FDA requirements and international medical device regulations, creates significant barriers to entry. Supported by continuous innovation, direct customer engagement, recurring procedure-driven demand, and strategic acquisitions, Stryker has built a scalable business model that enables it to deliver advanced medical technologies while supporting sustainable long-term growth.<\/p>\n\n\n\n

How Stryker Makes Money<\/strong><\/h2>\n\n\n\n

Stryker generates revenue <\/a>by developing, manufacturing, and selling medical devices, surgical technologies, orthopedic implants, and healthcare solutions<\/strong> to hospitals, physicians, and other healthcare providers worldwide. Its business is organized into two reportable segments\u2014MedSurg and Neurotechnology<\/strong> and Orthopaedics<\/strong>\u2014which together serve a broad range of medical specialties. Revenue is generated from the sale of capital equipment, implants, surgical instruments, disposable medical products, robotic-assisted surgical systems, and digital healthcare technologies. By combining recurring demand from surgical procedures with ongoing product innovation, Stryker has built a diversified and resilient revenue model. In 2025<\/strong>, the company reported net sales of $25.1 billion<\/strong>.<\/p>\n\n\n\n

The MedSurg and Neurotechnology<\/strong> segment is Stryker’s largest revenue contributor. In 2025<\/strong>, it generated $15.6 billion<\/strong>, representing 62% of total net sales<\/strong>. This segment includes five businesses: Instruments, Endoscopy, Medical, Vascular, and Neuro Cranial<\/strong>. Revenue comes from products such as surgical equipment, operating room technologies, navigation systems, endoscopic imaging platforms, patient handling equipment, emergency medical devices, intensive care disposable products, stroke treatment devices, and neurosurgical technologies. The segment also benefits from growing demand for AI-assisted clinical communication platforms and minimally invasive procedures, as well as recent acquisitions that expanded Stryker’s vascular and wound care offerings.<\/p>\n\n\n\n

The Orthopaedics<\/strong> segment generated $9.5 billion<\/strong> in 2025<\/strong>, accounting for 38% of total net sales<\/strong>. Revenue is primarily derived from implants and surgical technologies used in knee, hip, shoulder, trauma, extremity, ankle, and spinal procedures<\/strong>. Within the segment, Trauma and Extremities<\/strong> represented the largest product category, followed by Knees<\/strong> and Hips<\/strong>. Stryker also generates revenue from its Mako SmartRobotics<\/strong> platform, which combines robotic-assisted surgery with advanced implant systems and digital planning software. As more hospitals adopt Mako systems, the installed base supports future demand for compatible implants, surgical instruments, and procedure-specific consumables, creating recurring revenue opportunities over time.<\/p>\n\n\n\n

In addition to product sales, Stryker benefits from long-term relationships with hospitals and healthcare systems. Many of its products are used repeatedly in surgical procedures, creating recurring demand for implants, disposable medical products, and replacement instruments. The company’s capital equipment\u2014including surgical navigation systems, endoscopic imaging platforms, emergency medical devices, and robotic-assisted surgical systems\u2014also generates ongoing revenue through upgrades, accessories, consumables, and continued product adoption. This combination of capital equipment sales and recurring procedure-driven demand provides a stable and diversified revenue base.<\/p>\n\n\n\n

Innovation and strategic acquisitions further strengthen Stryker’s revenue model. During 2025, acquisitions including Inari Medical<\/strong>, Guard Medical<\/strong>, and Advanced Medical Balloons<\/strong> expanded the company’s portfolio in vascular intervention, surgical wound care, and patient management. At the same time, continued investment in robotic surgery, artificial intelligence, minimally invasive technologies, and digital operating room solutions helps Stryker introduce new products that drive future sales. Supported by a diversified portfolio, direct relationships with healthcare providers, and continuous innovation, Stryker has built one of the world’s leading medical technology businesses with multiple complementary sources of revenue.<\/p>\n\n\n\n

Future Outlook<\/strong><\/h2>\n\n\n\n

Stryker’s future growth strategy is centered on continued innovation, portfolio expansion, and the adoption of advanced medical technologies that improve patient outcomes and healthcare efficiency. The company plans to strengthen its leadership in robotic-assisted surgery<\/strong> by expanding the global footprint of Mako SmartRobotics<\/strong>, which is already available in more than 45 countries<\/strong>, while introducing new applications such as Mako Total Hip with Advanced Primary and Revision<\/strong> and preparing for the broader commercial launch of Mako Shoulder<\/strong>. Stryker also continues to invest in minimally invasive therapies, digital operating room technologies, artificial intelligence-assisted clinical communication, and next-generation medical devices to address evolving healthcare needs.<\/p>\n\n\n\n

Alongside internal innovation, Stryker expects strategic acquisitions, research and development investments, and international expansion to remain important drivers of long-term growth. Recent acquisitions, including Inari Medical<\/strong>, Guard Medical<\/strong>, and Advanced Medical Balloons<\/strong>, have expanded the company’s capabilities in vascular intervention, surgical wound care, and patient management. Supported by its broad product portfolio, strong direct relationships with healthcare providers, extensive intellectual property portfolio, and commitment to regulatory compliance, Stryker believes it is well positioned to capitalize on increasing demand for advanced medical technologies while continuing its mission of making healthcare better for patients around the world.<\/p>\n","protected":false},"excerpt":{"rendered":"

Discover the Stryker business model and how Stryker makes money through medical devices, orthopedic implants, surgical equipment, robotics, neurotechnology, and healthcare innovation.<\/p>\n","protected":false},"author":1,"featured_media":24844,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[166],"tags":[],"class_list":{"0":"post-24843","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business-model"},"yoast_head":"\nStryker Business Model: How Stryker Makes Money - The Strategy Story<\/title>\n<meta name=\"description\" content=\"Discover the Stryker business model and how Stryker makes money through medical devices, orthopedic implants, surgical equipment, robotics, neurotechnology, and healthcare innovation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stryker Business Model: How Stryker Makes Money - The Strategy Story\" \/>\n<meta property=\"og:description\" content=\"Discover the Stryker business model and how Stryker makes money through medical devices, orthopedic implants, surgical equipment, robotics, neurotechnology, and healthcare innovation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/\" \/>\n<meta property=\"og:site_name\" content=\"The Strategy Story\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-12T12:32:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-12T12:32:45+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/07\/thisisengineering-ZPeXrWxOjRQ-unsplash.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"427\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/\",\"url\":\"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/\",\"name\":\"Stryker Business Model: How Stryker Makes Money - The Strategy Story\",\"isPartOf\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\"},\"datePublished\":\"2026-07-12T12:32:01+00:00\",\"dateModified\":\"2026-07-12T12:32:45+00:00\",\"author\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/2f78fc259746b58da95619cc4c1a7972\"},\"description\":\"Discover the Stryker business model and how Stryker makes money through medical devices, orthopedic implants, surgical equipment, robotics, neurotechnology, and healthcare innovation.\",\"breadcrumb\":{\"@id\":\"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thestrategystory.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stryker Business Model: How Stryker Makes Money\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#website\",\"url\":\"https:\/\/thestrategystory.com\/blog\/\",\"name\":\"The Strategy Story\",\"description\":\"Simplifying Business Strategies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/2f78fc259746b58da95619cc4c1a7972\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/12ad6ed4e2acceb2ca63d603c4f581010634a4b2ec37d408ef885f33d01bac54?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/12ad6ed4e2acceb2ca63d603c4f581010634a4b2ec37d408ef885f33d01bac54?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"http:\/\/thestrategystory.com\/blog\"],\"url\":\"https:\/\/thestrategystory.com\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stryker Business Model: How Stryker Makes Money - The Strategy Story","description":"Discover the Stryker business model and how Stryker makes money through medical devices, orthopedic implants, surgical equipment, robotics, neurotechnology, and healthcare innovation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/","og_locale":"en_US","og_type":"article","og_title":"Stryker Business Model: How Stryker Makes Money - The Strategy Story","og_description":"Discover the Stryker business model and how Stryker makes money through medical devices, orthopedic implants, surgical equipment, robotics, neurotechnology, and healthcare innovation.","og_url":"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/","og_site_name":"The Strategy Story","article_published_time":"2026-07-12T12:32:01+00:00","article_modified_time":"2026-07-12T12:32:45+00:00","og_image":[{"width":640,"height":427,"url":"http:\/\/thestrategystory.com\/blog\/wp-content\/uploads\/2026\/07\/thisisengineering-ZPeXrWxOjRQ-unsplash.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/","url":"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/","name":"Stryker Business Model: How Stryker Makes Money - The Strategy Story","isPartOf":{"@id":"https:\/\/thestrategystory.com\/blog\/#website"},"datePublished":"2026-07-12T12:32:01+00:00","dateModified":"2026-07-12T12:32:45+00:00","author":{"@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/2f78fc259746b58da95619cc4c1a7972"},"description":"Discover the Stryker business model and how Stryker makes money through medical devices, orthopedic implants, surgical equipment, robotics, neurotechnology, and healthcare innovation.","breadcrumb":{"@id":"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/thestrategystory.com\/blog\/stryker-business-model-how-stryker-makes-money\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thestrategystory.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Stryker Business Model: How Stryker Makes Money"}]},{"@type":"WebSite","@id":"https:\/\/thestrategystory.com\/blog\/#website","url":"https:\/\/thestrategystory.com\/blog\/","name":"The Strategy Story","description":"Simplifying Business Strategies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thestrategystory.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/2f78fc259746b58da95619cc4c1a7972","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thestrategystory.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/12ad6ed4e2acceb2ca63d603c4f581010634a4b2ec37d408ef885f33d01bac54?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/12ad6ed4e2acceb2ca63d603c4f581010634a4b2ec37d408ef885f33d01bac54?s=96&d=mm&r=g","caption":"admin"},"sameAs":["http:\/\/thestrategystory.com\/blog"],"url":"https:\/\/thestrategystory.com\/blog\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/24843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/comments?post=24843"}],"version-history":[{"count":2,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/24843\/revisions"}],"predecessor-version":[{"id":24846,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/posts\/24843\/revisions\/24846"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/media\/24844"}],"wp:attachment":[{"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/media?parent=24843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/categories?post=24843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thestrategystory.com\/blog\/wp-json\/wp\/v2\/tags?post=24843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}